| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.2B | $9.8B | $10.5B | $9.2B | $1.9B | $1.5B | $1.3B | $1.1B |
| Cost of Revenue | $4.8B | $3.9B | $4.2B | $3.6B | $2.8B | $2.4B | $1.9B | $1.4B |
| Gross Profit | — | — | — | — | $1.2B | $0.8B | $0.7B | $0.7B |
| R&D Expense | $1.4B | $1.3B | $1.3B | $1.1B | $0.9B | $0.9B | $0.7B | $0.6B |
| SG&A Expense | $1.0B | $1.0B | $1.0B | $0.9B | $0.7B | $0.7B | $0.6B | $0.4B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $4.1B | $2.8B | $3.4B | $3.3B | $0.6B | $0.4B | $0.2B | $0.3B |
| EPS (Basic) | $30.53 | $20.41 | $24.28 | $22.07 | $4.14 | $2.65 | $1.36 | $2.24 |
| EPS (Diluted) | $30.37 | $20.28 | $24.15 | $21.92 | $4.10 | $2.63 | $1.35 | $2.22 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.1B | $15.4B | $14.1B | $12.6B | $10.3B | $9.3B | $9.0B | $5.6B |
| Current Assets | $10.7B | $10.0B | $8.4B | $7.2B | $5.7B | $4.7B | $4.3B | $4.5B |
| Cash & Equivalents | $2.1B | $2.0B | $1.9B | $1.6B | $1.4B | $0.5B | $1.0B | $1.4B |
| Total Liabilities | $11.4B | $12.1B | $11.2B | $11.2B | $6.9B | $6.6B | $6.3B | $4.0B |
| Current Liabilities | $4.1B | $4.7B | $3.7B | $2.9B | $2.1B | $1.7B | $1.8B | $1.2B |
| Stockholders' Equity | $4.7B | $3.4B | $2.9B | $1.4B | $3.4B | $2.7B | $2.7B | $1.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.1B | $3.3B | $3.7B | $3.3B | $2.2B | $1.8B | $1.2B | $1.2B |
| Investing Cash Flow | $-0.2B | $-1.5B | $-0.5B | $-0.9B | $-0.5B | $-0.3B | $-1.2B | $0.3B |
| Capital Expenditures | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.1B | $0.1B |
| Financing Cash Flow | $-3.8B | $-1.8B | $-2.8B | $-2.3B | $-1.5B | $-1.3B | $-0.4B | $-1.3B |